Key result
Cross-reactive autoantibodies accurately classify MIS-C from controls with an AUC of ~0.93.
Why the study?
The pathophysiological mechanism linking SARS-CoV-2 infection to multisystem inflammatory syndrome in children (MIS-C) remains unknown.
Case-Control (n=292)
Yes
Effect estimate: AUC 0.93
Demonstrates a pathophysiological link between SARS-CoV-2 infection and MIS-C via cross-reactive immune responses to the viral N protein and host protein SNX8.
May suggest autoimmune mechanisms in MIS-C; hypothesis-generating and should not yet change practice.
Multisystem inflammatory syndrome in children (MIS-C) is a severe, post-infectious sequela of SARS-CoV-2 infection, yet the pathophysiological mechanism connecting the infection to the broad inflammatory syndrome remains unknown. Here we leveraged a large set of MIS-C patient samples (n=199) to identify a distinct set of host proteins that are differentially targeted by patient autoantibodies relative to matched controls. We identified an autoreactive epitope within SNX8, a protein expressed primarily in immune cells which regulates an antiviral pathway associated with MIS-C pathogenesis. In parallel, we also probed the SARS-CoV-2 proteome-wide MIS-C patient antibody response and found it to be differentially reactive to a distinct domain of the SARS-CoV-2 nucleocapsid (N) protein relative to controls. This viral N region and the mapped SNX8 epitope bear remarkable biochemical similarity. Furthermore, we find that many children with anti-SNX8 autoantibodies also have T-cells cross-reactive to both SNX8 and this distinct domain of the SARS-CoV-2 N protein. Together, these findings suggest that MIS-C patients develop a distinct immune response against the SARS-CoV-2 N protein that is associated with cross reactivity to the self-protein SNX8, demonstrating a link from the infection to the inflammatory syndrome.
No takes yet. Share an insight, caveat, or question.
Bodansky et al. (2023) conducted a case-control in Multisystem inflammatory syndrome in children (MIS-C) (n=292). Multisystem inflammatory syndrome in children (MIS-C) vs. Children with asymptomatic or mild SARS-CoV-2 infection without MIS-C was evaluated on Classification of MIS-C from at-risk controls using autoreactivity to ERFL, SNX8, and KDELR1 proteins (AUC 0.93). Children with MIS-C exhibited a distinct cross-reactive autoimmune response involving autoantibodies to SNX8 and the SARS-CoV-2 nucleocapsid protein, which accurately classified MIS-C from controls with an AUC of 0.93.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: